本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aclaris Therapeutics

5.64
+0.32006.02%
盤後5.800.1600+2.84%19:30 EDT
成交量:583.84萬
成交額:3,276.53萬
市值:8.30億
市盈率:-9.62
高:5.72
開:5.29
低:5.29
收:5.32
52周最高:6.60
52周最低:1.74
股本:1.47億
流通股本:1.10億
量比:2.09
換手率:5.31%
股息:- -
股息率:- -
每股收益(TTM):-0.5861
每股收益(LYR):-0.5300
淨資產收益率:-59.10%
總資產收益率:-28.98%
市淨率:6.66
市盈率(LYR):-10.64

資料載入中...

2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

重要事件披露

Form 8-K - Current report
2024/02/05

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/02/01

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/16

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/20

重要事件披露

Form 8-K - Current report
2023/12/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/11

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/25

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/13

重要事件披露

Form 8-K - Current report
2023/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/06

重要事件披露

Form 8-K - Current report
2023/10/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/18

重要事件披露

Form 8-K - Current report
2023/09/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/07

重要事件披露

Form 8-K - Current report